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Abstract: Aggregates of amyloidogenic peptides are in-
volved in the pathogenesis of several degenerative disor-
ders. Herein, an iridium(III) complex, Ir-1, is reported as
a chemical tool for oxidizing amyloidogenic peptides upon
photoactivation and subsequently modulating their aggre-
gation pathways. Ir-1 was rationally designed based on mul-
tiple characteristics, including 1) photoproperties leading to
excitation by low-energy radiation; 2) generation of reactive
oxygen species responsible for peptide oxidation upon pho-
toactivation under mild conditions; and 3) relatively easy in-
corporation of a ligand on the IrIII center for specific interac-
tions with amyloidogenic peptides. Biochemical and bio-
physical investigations illuminate that the oxidation of repre-
sentative amyloidogenic peptides (i.e. , amyloid-b, a-synu-
clein, and human islet amyloid polypeptide) is promoted by
light-activated Ir-1, which alters the conformations and ag-
gregation pathways of the peptides. Additionally, their po-
tential oxidation sites are identified as methionine, histidine,
or tyrosine residues. Overall, our studies on Ir-1 demonstrate
the feasibility of devising metal complexes as chemical tools
suitable for elucidating the nature of amyloidogenic pep-
tides at the molecular level, as well as controlling their ag-
gregation.
Introduction
Amyloidogenic peptides are found in human degenerative dis-
eases [e.g. , amyloid-b (Ab) for Alzheimer’s disease, a-synuclein
(a-Syn) for Parkinson’s disease, and human islet amyloid poly-
peptide (hIAPP) for type II diabetes].[1] Amyloidogenic peptides
have aggregate-prone properties to form b-strand fibrils
through oligomeric conformations, and their aggregation has
been suggested to be linked to the pathogenesis of degenera-
tive disorders.[1] Thus, a variety of approaches have been devel-
oped to regulate or suppress the aggregation pathways of
amyloidogenic peptides.[1b, 2] Among such methods, peptide
modifications, including peptide oxidation, have been recently
implicated as a strategy suitable for modulation of amyloido-
genic peptide aggregation (Figure 1 a).[3]
To trigger the oxidation of peptides, some chemical re-
agents, such as metal ions, have been utilized.[3b, 4] Metal ions
are frequently used for peptide oxidation; however, they re-
quire harsh additional oxidants.[3b, 4] In addition, chemical re-
agents capable of generating oxidants from O2 upon photoac-
tivation have been developed for use as photosensitizers in
various fields because light is a readily accessible resource.[3a, 5]
A series of organic molecules, such as riboflavin, rose bengal,
methylene blue, and porphyrins, have been used as photoin-
duced reagents;[3a, 5b–h] however, 1) many of them have relative-
ly lower quantum yields than those of photoactivatable transi-
tion-metal complexes;[6] and 2) some organic agents are less
stable, which potentially indicates their degradation upon irra-
diation.[5a, i] Photoactivatable metal complexes present relatively
high quantum yields, structural stability, and tunable geome-
tries and properties upon ligand substitution.[5a,i] Due to these
beneficial aspects, multiple metal complexes have been de-
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signed and mediated for photoinduced oxidation of pepti-
des.[5j–m] One inorganic complex, [Ru(bpy)3]
2 + (bpy = 2,2’-bipyri-
dine), has been frequently employed for oxidative modifica-
tions of peptides through light exposure.[5k–m] To achieve pep-
tide oxidation, however, this ruthenium(II) complex still needs
an additional electron acceptor (e.g. , ammonium persulfate),
which could lead to cytotoxicity and limit its applications.[5k–m, 7]
Thus, robust inorganic complexes able to efficiently oxidize
peptides simply by light introduction without the assistance of
harsh additives would be of significant value for gaining
a greater understanding of peptide-related chemistry and biol-
ogy.
Herein, we report an iridium(III) complex, Ir-1 (Figure 1 b), as
a chemical tool for the oxidation of amyloidogenic peptides
with subsequent control of their aggregation under mild con-
ditions that only include readily available O2 and visible light.
Ir-1 was rationally designed as such a tool through incorporat-
ing the general properties of IrIII complexes previously reported
for various applications, including photoactivation, formation
of reactive oxygen species (ROS) upon light exposure, and rela-
tively stable octahedral geometry, as well as relatively easy in-
troduction of a ligand containing a structural moiety, suggest-
ed to be important for interactions with amyloidogenic pep-
tides, on the IrIII center.[5a, 8] Representative amyloidogenic pep-
tides (i.e. , Ab, a-Syn, and hIAPP) were indicated to be noticea-
bly oxidized upon treatment of Ir-1 with photoactivation
under aerobic conditions, as monitored by electrospray ioniza-
tion mass spectrometry (ESI-MS), and their oxidation sites (as
potential sites, methionine, histidine, and tyrosine residues)
were identified by tandem MS (ESI-MS2). Even with oxidative
modifications of a few residues in these amyloidogenic pep-
tides, the aggregation pathways were noticeably modulated,
resulting in distinct morphological features (e.g. , smaller-sized
or amorphous peptide species, instead of fibrils). Taken togeth-
er, our rational design and investigations into Ir-1 illustrate the
potential of transition metal complexes as chemical tools for
the oxidative modification of amyloidogenic peptides simply
by employing light and O2. In addition, our studies corroborate
that small changes in amyloidogenic peptides, such as oxida-
tion at a few specific residues, are able to transform overall
peptide aggregation pathways; this suggests novel and viable
directions for amyloid management (Figure 1 a).
Results and Discussion
Rational design of Ir-1 for oxidation of amyloidogenic
peptides
For the oxidation of amyloidogenic peptides simply upon pho-
toactivation under mild conditions, Ir-1 (Figure 1 b) was ration-
ally designed as a chemical tool by taking into account the
characteristics found in previously reported photoactivatable
IrIII complexes, as well as specificity for amyloidogenic pep-
tides: 1) photoproperties with relatively low-energy radiation
(i.e. , visible light) ;[8d,e] 2) the ability to produce ROS [e.g. , singlet
oxygen (1O2)] from redundant O2, which is responsible for pep-
tide oxidation, upon photoactivation;[5a, 8c] 3) robust octahedral
coordination, which can provide relative structural stability
without any structural modifications when light is introdu-
ced;[8c] 4) strong spin-orbit coupling of the IrIII center, which
could facilitate electronic transitions without the assistance of
additional electron acceptors;[8d,e] and 5) incorporation of
a ligand (1) containing a dimethylamino group, which is sug-
gested to be crucial for interactions with amyloidogenic pepti-
des,[8a,b] onto the IrIII center (Figure 1 b).
Ir-1 was obtained in relatively high yield (ca. 80 %) through
previously known two-step procedures with slight modifica-
tions, as depicted in Figure 1 b.[9] Moreover, Ir-1 is easily photo-
activatable under mild conditions [e.g. , excitation with visible
light (e (463 nm) = 5.78 (: 0.12) V 103 m@1 cm@1; Table S1 in
the Supporting Information) and aerobic conditions] as shown
by its quantum yield for phosphorescence [Fp = 0.41 (: 0.02) ;
Table S1 in the Supporting Information] . The ability of Ir-1 to
generate singlet oxygen (1O2) from triplet dioxygen (
3O2) was
also confirmed by determining the quantum yield of 1O2 [Fs =
0.25 (: 0.03) ; Table S1 in the Supporting Information]. Overall,
an octahedral IrIII complex, Ir-1, was constructed as a photoacti-
vatable tool to oxidize amyloidogenic peptides without the
need for harsh conditions through relatively easy synthetic
routes with a high yield, and demonstrated to generate oxi-
dants (i.e. , 1O2) from readily accessible O2.
Oxidative modifications of amyloidogenic peptides by Ir-1
To investigate whether the oxidation of amyloidogenic pep-
tides by Ir-1 under aerobic conditions would occur with light
activation, three amyloidogenic peptides (i.e. , Ab, a-Syn, and
hIAPP found in Alzheimer’s disease, Parkinson’s disease, and
type II diabetes, respectively) were chosen as representative
amyloidogenic peptides, and the resultant monomeric peptide
species upon treatment with Ir-1 were first monitored by
means of ESI-MS (Figure 2). These three amyloidogenic pep-
tides were observed to be oxidized with the addition of light-
activated Ir-1 under aerobic conditions. Without light, even in
Figure 1. Schematic description of amyloidogenic peptide aggregation and
chemical structures of Ir-1 and 1. As shown in (a), oxidation of amyloidogen-
ic peptides could control their aggregation pathways. (b) Synthetic routes to
Ir-1.
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the presence of Ir-1, all amyloidogenic peptides were in non-
oxidized forms (Figure 2, middle, gray). In the case of Ab40, the
oxidized Ab monomers had a 16 Da increase in mass from
nonoxidized peptides; this implied the incorporation of one
oxygen atom into the peptide (Figure 2 a, bottom, blue). Nota-
bly, ligand 1 alone was not able to oxidize Ab40 (Figure S1 in
the Supporting Information). Similar to Ab40, doubly oxidized
a-Syn with a 32 Da increase in mass, relative to that of the
native peptide, was indicated; this suggested the introduction
of two oxygen atoms into the peptide (Figure 2 b, bottom,
blue). Slightly different from both Ab and a-Syn, singly oxi-
dized monomeric hIAPP presented a 14 Da difference in mass
from nonoxidized peptides (Figure 2 c, bottom, blue). A 14 Da
increase in mass could result from the addition of one oxygen
atom to hIAPP, along with deprotonation.[3a, 5f, 10]
Second, we examined whether amyloidogenic peptide oligo-
mers (focusing on Ab oligomers) by Ir-1 could be oxidized
with light activation under aerobic conditions. From the sam-
ples containing Ab and Ir-1 upon exposure to light and O2, the
oxidation of both dimers and larger oligomers was revealed
(Figure 3 a and Figure S2 in the Supporting Information). As
demonstrated in Figure 3 a, multiple oxygen atoms (e.g. , for
dimers, up to seven oxygen atoms) were indicated to be incor-
porated into the oxidized oligomers.
Moreover, structural changes to monomeric and oligomeric
peptide species accompanied by oxidation were probed by
means of ion mobility mass spectrometry (IM-MS), which ena-
bled to characterize conformations based on the mobility of
ions passing through a cell filled with neutral gas.[11] In the
case of Ab monomers, there was no remarkable difference in
arrival time distributions (ATDs) between singly oxidized and
nonoxidized Ab40 monomers (Figure S3 in the Supporting In-
formation). Distinguishable from Ab monomers, a change in
the IM-MS data of Ab40 dimers upon oxidation was presented
at two dominant ATDs, centered at 10.80 and 15.55 ms, respec-
tively (Figure 3 b). Nonoxidized Ab40 dimers exhibited greater
dominance in the larger ATD, whereas the oxidized dimers had
the opposite tendency, which suggested that peptide oxida-
tion could lead to structural compaction in the dimers. Al-
though structural details of oxidized dimers have not been elu-
cidated, their structural compaction might assist in modulating
peptide aggregation because previous studies indicated that
conformationally compact Ab species could alter peptide ag-
gregation pathways to form amorphous aggregates.[2b–e]
Furthermore, the oxidation of a nonamyloidogenic struc-
tured protein, ubiquitin, was also investigated when Ir-1 was
added with light under aerobic conditions. Ubiquitin was se-
lected as an archetypal structured protein because all secon-
Figure 2. Oxidation of amyloidogenic peptides by Ir-1 upon light activation. Mass spectrometric analyses of amyloidogenic peptides [(a) Ab40, (b) a-Syn, and
(c) hIAPP] upon treatment with Ir-1 in the presence of light. Oxidized peptide ions are indicated with red asterisks, and the number of asterisks indicates the
number of oxygen atoms incorporated into the peptides. Conditions: [peptide] = 100 mm ; [Ir-1] = 500 mm ; pH 7.4; 37 8C; 1 h; no agitation; 1 sun light for
10 min (for samples treated with light) ; aerobic conditions. Details for the assignment of oxidized peaks are included in the Experimental Section.
Figure 3. Oxidation of Ab40 dimers by Ir-1 upon photoactivation. (a) ESI-MS
spectra for + 5-charged dimers with Ir-1 in the absence and presence of
light. The oxidized dimers are only detected by Ir-1 with light exposure
(bottom, blue). The number of red asterisks indicates the number of oxygen
atoms incorporated into Ab40 dimers. (b) ATDs for nonoxidized (top and
middle) and tetraoxidized dimers (bottom). Each ion selected for IM-MS anal-
ysis is indicated with gray arrows in (a). The oxidized dimer incorporated
with four oxygen atoms presents the higher abundance in the distribution
with short drift time (bottom) than that of nonoxidized Ab40 (top and
middle), which implies that structural compaction can be induced by oxida-
tion. Conditions: [Ab40] = 100 mm ; [Ir-1] = 500 mm ; pH 7.4; 37 8C; 1 h; no ag-
itation; 1 sun light for 10 min (for samples treated with light); aerobic condi-
tions.
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dary structures (e.g. , a-helix, b-strand, and random coil) could
be found in ubiquitin.[12] Ubiquitin treated with Ir-1 was shown
to be oxidized with light exposure under aerobic conditions
(Figure S4 in the Supporting Information, bottom, blue); how-
ever, oxidized ubiquitin was significantly less abundant than
the oxidized forms of intrinsically disordered amyloidogenic
peptides (i.e. , Ab40, a-Syn, and hIAPP). Overall, oxidative modifi-
cations of amyloidogenic peptides, lacking ordered structures,
are more readily achieved over structured peptides by Ir-
1 under mild conditions, including light and O2, which could
direct structural compaction; this supports the utilization of Ir-
1 as a photoactivatable tool for the oxidation of amyloidogenic
peptides.
Identification of oxidation sites in amyloidogenic peptides
The resultant oxidized amyloidogenic peptides, produced by
the addition of Ir-1 with light exposure under aerobic condi-
tions, were further studied by ESI-MS2 to determine the oxida-
tion sites in the peptides.[2d,e] The fragment ions generated by
selectively applying collisional energy to the singly and doubly
oxidized amyloidogenic peptides were analyzed (Figure 4).
First, the oxidation sites in Ab40 were identified. The singly oxi-
dized fragments, highlighted in red, were observed in b frag-
ments, which were cleaved from the N-terminus (Figure 4 b).
All b fragments smaller than b13 existed as nonoxidized forms,
whereas those larger than b34 represented only oxidized frag-
ments. Methionine 35 (M35) is known to be the most readily
oxidizable amino acid in Ab.[3j] If oxidation occurred only at
M35, all fragments smaller than b35 would not be oxidized (Fig-
ure 4 a); however, oxidized b fragments were indicated to be
smaller than b35, which implied the existence of other oxida-
tion sites (Figure 4 b). Based on previously reported studies,
other possible oxidation sites could be histidine residues (i.e. ,
H13, H14).[4c, 14] In the ESI-MS2 spectrum for doubly oxidized
Ab40, there was no oxidized fragment smaller than b13 (Fig-
ure 4 d). Because fragments from b13 to b34 only existed in
singly oxidized forms (highlighted in red in Figure 4), this
region would include one oxidation site, possibly H13 or H14.
All fragments larger than b34 were doubly oxidized (denoted in
green), which implied the incorporation of one oxygen atom
into M35 to generate a sulfoxide form (Figure 4 c and d).
For further analysis of the oxidation sites in Ab, Ab40 treated
with Ir-1 in the absence and presence of light was evaluated
by 2D band-selective optimized flip-angle short transient het-
eronuclear multiple quantum correlation (SOFAST-HMQC) NMR
spectroscopy (Figure 5 and Figure S5 in the Supporting Infor-
mation). In the absence of light, minimal chemical shift pertur-
bations (CSPs) of uniformly 15N-labeled Ab40 appeared upon in-
cubation with Ir-1 (Figure 5 b), which implied no significant in-
teraction of Ir-1 with the peptide. Following exposure of the
Ab samples containing Ir-1 to light, a dramatic increase in the
CSPs at V12, D23, and M35 was observed (Figure 5 c). A notice-
able change in the CSP of M35 suggests that there are interac-
Figure 4. Identification of the oxidation sites in Ab40. (a and c) The peptide
sequence and annotation for ESI-MS2 and (b and d) ESI-MS2 spectra for
singly and doubly oxidized Ab40. Singly and doubly oxidized b fragments (N-
terminal fragment ions) or y fragments (C-terminal fragment ions) are denot-
ed in red and green, respectively. The peaks assigned as triangles (b16 and
b17) indicate that the loss of a water molecule occurs at serine, threonine,
glutamate, or aspartate residues in these fragment ions.[13]
Figure 5. SOFAST-HMQC NMR studies of uniformly 15N-labeled Ab40 mono-
mer upon treatment with Ir-1 with and without light. (b and c) The chemical
shift perturbations (CSPs) for each spectrum [in the absence (Figure S5 in
the Supporting Information) or presence of light (a)] , relative to the spec-
trum of Ab40 without Ir-1, were calculated. Conditions: [
15N-labeled Ab40] =
80 mm ; [Ir-1] = 160 mm ; pH 7.4; 37 8C; ambient light for 1 h (for samples
treated with light); aerobic conditions. *Residues could not be resolved for
analysis.
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tions near M35, which is consistent with observation moni-
tored by ESI-MS2. In the case of histidine residues, although
they were not well resolved within the spectra due to peak
overlap, the enhanced CSP of V12, proximately located to H13
or H14, could be expected, which proposed oxidative modifi-
cations at H13 or H14, as shown in our ESI-MS2 studies. Nota-
bly, in the NMR spectra, D23 was adjacent to M35 with some
overlap, so the shift of M35 might affect its CSP. Thus, our
NMR data support that Ab40 is oxidized at specific sites (poten-
tially, M35, H13, and H14) by Ir-1 upon light stimulation under
aerobic conditions.
Potential oxidation sites in the other amyloidogenic peptides
(i.e. , a-Syn and hIAPP), when treated with Ir-1 in the presence
of light under aerobic conditions, were also investigated by
means of ESI-MS2 (Figure 6). When the collisional energy was
applied at doubly oxidized a-Syn (Figure 6 a and b), no oxida-
tion was found in small N-terminal fragments; this reflects that
oxidation at M1 and M5 rarely occurs. The C-terminal fragment
y13 was detected in a nonoxidized form, but b119 was present in
both oxidized and nonoxidized forms. One oxidation site exist-
ed between P120 and M127, and the most plausible location
was M127. Since singly oxidized b116 and b119 ions were relative-
ly abundant, M116 was also estimated to be possibly oxidized.
There were oxidized fragments smaller than b116, such as b63,
b65, and b66, which implied that there were oxidation sites
other than M116 and M127. Based on our investigations for ox-
idation sites in Ab40, the histidine residue in a-Syn (i.e. , H50)
could be an oxidation site. Additionally, in the ESI-MS2 spectra
of singly and doubly oxidized hIAPP (Figure 6 c–e), peptide oxi-
dation was observed in fragments larger than b18 ; this was in-
dicative of H18 as a potential oxidation site. Fragments be-
tween b18 and b32, however, appeared in both oxidized and
nonoxidized forms, which suggested that there was another
oxidation site apart from H18. In the spectrum of doubly oxi-
dized hIAPP (Figure 6 e), no doubly oxidized ion was displayed
other than the whole peptide itself, which possibly revealed
that Y37 might be the second oxidation site.
Previous studies proposed that methionine, histidine, and ty-
rosine residues in amyloidogenic peptides were susceptible to
oxidative modification, which could affect their aggregation
behavior.[3e, h, j, 15] Particularly, oxidative modifications of methio-
nine residues have been reported to inhibit b-strand formation
of amyloidogenic peptides.[3h, j, 15] Incorporation of oxygen
atoms into methionine residues could provide partial negative
charges and further enhance the polarity of peptides.[3c, h, 15] In
the case of Ab, the increased polarity of oxidized M35 could
reduce hydrophobic contacts in the C-terminal region and de-
stabilize a b-strand structure in which M35 proximately inter-
acts with the aromatic ring of F19.[3h, 15] Along with a change in
polarity, greater structural disorder and reduced helicity were
also found in methionine-oxidized a-Syn.[3c, 16] Specifically, oxi-
dation at M116 and M127 presumably disrupts a-Syn aggrega-
tion because these residues are suggested to mediate long-
range interactions with the central hydrophobic regions.[17]
Other important oxidation sites are histidine residues. Due to
its structural features, such as an imidazole ring and two proto-
nation states, histidine has versatile roles in multiple interac-
tions (e.g. , cationic–p interactions, p–p stacking, hydrogen–p
interactions, coordination, and hydrogen bonding).[18] Depend-
ing on pH, histidine can present different protonation states
that have effects on the molecular behavior of amyloidogenic
peptides, including aggregation, through alteration of the
strength of interactions.[18, 19] In addition, histidine is known as
a metal binding site in amyloidogenic peptides.[20] Binding of
metal ions (e.g. , CuII, ZnII) to peptides is shown to accelerate
amyloidogenic peptide aggregation or induce the formation
and stabilization of toxic oligomeric aggregates.[1b, 20b, c, 21] Upon
the formation of 2-oxo-histidine, metal binding affinities were
reported to be substantially decreased; thus, oxidative modifi-
cations of histidine residues might destabilize complexes of
amyloidogenic peptides with metal ions.[20e, 22] Collectively, me-
thionine, histidine, and/or tyrosine residues, the potential oxi-
dation sites of Ab, a-Syn, or hIAPP, which were suggested to
be essential for the properties and aggregation of these amy-
loidogenic peptides, were indicated by our MS and NMR stud-
ies. Oxidative modifications are present at a few specific resi-
Figure 6. Identification of oxidation sites in a-Syn and hIAPP. Sequences of
(a) a-Syn and (c) hIAPP. ESI-MS2 spectra for (b) doubly oxidized a-Syn, and
(d) singly and (e) doubly oxidized hIAPP. Nonoxidized, singly oxidized, and
doubly oxidized fragments are indicated in black, red, and green, respective-
ly.
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dues in amyloidogenic peptides, which might be able to mod-
ulate their aggregation pathways potentially through altering
intra- or intermolecular interactions critical for b-strand forma-
tion (see below).
Aggregation behavior influenced upon oxidation of
amyloidogenic peptides by light-activated Ir-1
Changes in size distribution
To investigate whether peptide oxidation could transmute the
aggregation of amyloidogenic peptides, two inhibition (Fig-
ure 7 a and Figure S6a in the Supporting Information) and dis-
aggregation (Figure S7a in the Supporting Information) experi-
ments[2b–e] were carried out mainly with Ab (two major iso-
forms, Ab40 and Ab42). Size distributions of the resultant Ab40
and Ab42 species treated with Ir-1 were evaluated by gel elec-
trophoresis with Western blotting (gel/Western blot) by using
an anti-Ab antibody (6E10).
In the inhibition studies (Figure 7 a), when fresh Ab40 was in-
cubated with Ir-1 in the presence of light under aerobic condi-
tions, various molecular weights (MWs) of peptide species
were visualized in the gel/Western blot (Figure 7 b, left). Dis-
tinct from the result with light exposure, Ir-1 could not gener-
ate diverse sizes of Ab aggregates without light. In addition,
when the ligands, 1 and 2-phenylquinoline (Figure 1 b), were
not coordinated to the IrIII center, they had no noticeable
effect on Ab aggregation, even with light under aerobic condi-
tions (Figure 7 b and Figure S6 in the Supporting Information).
When Ir-1 was incubated with fresh Ab42, similar reactivity
trends were presented to those with Ab40 (Figure 7 b, right). Di-
verse MW distributions of Ab42 species were shown with both
Ir-1 and light. Furthermore, the inhibition experiments were
conducted in the absence of O2 to verify if Ab aggregation
could be influenced upon oxidation of peptides by oxidants
generated by O2 with light-activated Ir-1. Ab aggregation path-
ways were not indicated to be varied under anaerobic condi-
tions, even in the presence of light (Figure 7 b, middle).
Moreover, in order to disassemble preformed Ab40 aggre-
gates or redirect their further aggregation upon oxidation with
Ir-1 in the presence of light and O2, the disaggregation experi-
ment was carried out (Figure S7 in the Supporting Informa-
tion). Similar to the inhibition studies, preformed Ab40 aggre-
gates were observed with a wide range of sizes only after
treatment with Ir-1 upon light exposure in the presence of O2.
Overall, our gel/Western blot results from both inhibition and
disaggregation experiments suggest that 1) Ir-1 is able to
transmute Ab aggregation pathways only with light activation
under aerobic conditions; and 2) the overall structure of Ir-
1 over individual structural components (e.g. , ligand 1) is es-
sential to alter Ab aggregation in the presence of both light
and O2. Combining the results with the control of light and O2,
it is demonstrated that Ab oxidation, triggered by photoacti-
vated Ir-1 with O2, could direct the modulation of peptide ag-
gregation pathways.
Morphological changes of amyloidogenic peptides
The degree of regulating the aggregation pathways of amyloi-
dogenic peptides was also monitored through morphological
changes visualized by transmission electron microscopy (TEM)
(Figure 7 c and d). From the TEM analyses, the resultant pep-
tides upon treatment with both Ir-1 and light under aerobic
conditions were observed to be smaller, while either structured
fibrils or large aggregates were indicated without light. In the
case of Ab40, the treatment of the peptide with Ir-1 induced
the formation of short and thin fibrils in the presence of both
light and O2 (Figure 7 c). Additionally, the morphologies of a-
Syn and hIAPP were also transformed to smaller amorphous
aggregates when Ir-1 was added with exposure of both light
and O2, instead of large aggregates or fibrils produced in the
absence of Ir-1 (Figure 7 d). Therefore, along with the gel/West-
ern blot data, our TEM studies imply that the aggregation of
amyloidogenic peptides could be transfigured upon treatment
with light-activated Ir-1 under aerobic conditions.
Figure 7. Effects of Ir-1 and 1 on peptide aggregation pathways. (a) Scheme of the inhibition experiments. (b) Analyses of the resultant Ab40 and Ab42 species
generated from various conditions [aerobic (left) and anaerobic (right) conditions] by gel/Western blot with an anti-Ab antibody (6E10). Lanes: (C) Ab40 or
Ab42 ; (1) Ab40 or Ab42 + 1; (Ir-1) Ab40 or Ab42 + Ir-1. (c and d) TEM images of the samples from (b) and the light-treated samples containing a-Syn or hIAPP
with and without Ir-1 (scale bar = 1 mm). Conditions: [peptide] = 25 mm ; [Ir-1 or 1] = 50 mm ; pH 7.4; 37 8C; 24 h; constant agitation; 1 sun light for 10 min
(for samples treated with light).
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Conclusion
Several strategies for understanding and suppressing the ag-
gregation of amyloidogenic peptides, found in amyloid-related
disorders and suggested to be linked to their pathogenesis,
have been developed. One of the tactics would be related to
oxidative modifications of the amino acid residues essential for
properties and aggregation behavior of peptides. For peptide
oxidation toward amyloidogenic peptides, an inorganic com-
plex, Ir-1, rationally designed to be a chemical tool that has
a relatively stable framework and is capable of generating oxi-
dants (e.g. , 1O2) from readily accessible O2 simply upon photo-
activation by using low-energy radiation.
On the basis of our biochemical and biophysical analyses, Ir-
1 is shown to significantly induce oxidative modifications of
amyloidogenic peptides, such as Ab, a-Syn, and hIAPP, fol-
lowed by alteration of their aggregation pathways. Peptide ox-
idation by photoactivated Ir-1 is more noticeable for amyloido-
genic peptides over well-structured nonamyloidogenic pep-
tides. By employing MS and NMR, the oxidation sites are indi-
cated to be potentially located at methionine, histidine, and/or
tyrosine residues in these amyloidogenic peptides. Through
minor alterations at a few specific residues in peptides by
using photoactivated Ir-1 under mild conditions, their aggre-
gation pathways can be modulated. Overall, our rational
design and fundamental investigations of Ir-1 demonstrate the
promise of an inorganic complex in being developed as
a chemical tool for oxidative modifications of amyloidogenic
peptides and subsequent control of their aggregation. Such
a tool will assist in advancing our fundamental understanding
toward amyloidogenic peptides, as well as providing insight




All reagents were purchased from commercial suppliers and used
as received, unless otherwise noted. Compound 1 (1 = methyl 4-
(dimethylamino)picolinate)[23] and the cyclometalated chloride-
bridged IrIII dimer ([Ir(C^N)2(m-Cl)2])
[24] were prepared by following
previously reported procedures. The prepared Ir-1 was character-
ized by NMR, FTIR, HRMS, and elemental analyzer on an Agilent
400-MR DD2 NMR spectrometer, Varian Cary 620/670 FTIR spec-
trometer (UNIST Central Research Facilities, Ulsan, Republic of
Korea), Bruker maXisTM HD Ultra-high resolution Q-TOF LC MS/MS
system (HRMS; The Cooperative Laboratory Center of Pukyong Na-
tional University, Busan, Republic of Korea), and Thermo Flash 2000
(UNIST Central Research Facilities, Ulsan, Republic of Korea), respec-
tively. Ab40 and Ab42 were purchased from Anygen (Ab40 =
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV, Ab42 =
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA; Nam-
myun, Jangseong-gun, Republic of Korea). a-Syn and hIAPP were




CA, USA); hIAPP = KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSN-
TY-NH2 (Daejeon, Republic of Korea)] . Ubiquitin was purchased
from Sigma Aldrich (ubiquitin = MQIFVKTLTGKTITLEVEPSDTIENV-
KAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG; St.
Louis, MO, USA). Double-distilled H2O (ddH2O) was obtained from
a Milli-Q Direct 16 system (Merck KGaA, Darmstadt, Germany). Irra-
diation with 1 sun was obtained with a Newport IQE-200 solar sim-
ulator (Irvine, CA, USA). ESI-MS and IM-MS analyses were per-
formed by using a Waters Synapt G2-Si quadrupole time-of-flight
ion mobility mass spectrometer equipped with an ESI source
(DGIST Center for Core Research Facilities, Daegu, Republic of
Korea). NMR studies of Ab with Ir-1 were conducted on a Bruker
Avance 600 MHz spectrometer equipped with a TCI triple-reso-
nance inverse detection cryoprobe. The data was processed by
using TOPSPIN 2.1 (Bruker) software and assignments were made
by using SPARKY 3.1134 software. Anaerobic reactions were per-
formed in a N2-filled glove box (Korea Kiyon, Bucheon-si, Gyeong-
gi-do, Republic of Korea). TEM images were taken by using a JEOL
JEM-1400 transmission electron microscope (UNIST Central Re-
search Facilities, Ulsan, Republic of Korea). Photophysical properties
were measured by using an Agilent Cary 100 UV/Vis spectropho-
tometer and a Varian Cary Eclipse fluorescence spectrophotometer
(UNIST Central Research Facilities, Ulsan, Republic of Korea). Time-
correlated single-photon counting (TCSPC) was performed for life-
time measurements with a Ti:sapphire laser Mira900 (Coherent,
Santa Clara, CA, USA), monochromator Acton series SP-2150i
(Princeton Instruments, Acton, MA, USA), and TCSPC module Pico-
Harp 300 (PicoQuant, Berlin, Germany) together with MCP-PMT
R3809U-59 (Hamamatsu, Shizuika-ken, Japan) and fitted by Pico-
Quant FluoFit software (UNIST Central Research Facilities, Ulsan, Re-
public of Korea).
Synthesis of Ir-1
2-Phenylquinoline (680 mg, 3.3 mmol) was added to a solution of
IrCl3·n H2O (500 mg, 1.7 mmol) in a mixture of 2-methoxyethanol
and H2O (3:1). The solution was heated at reflux under N2 (g) for
24 h. After cooling to room temperature, brown precipitates were
obtained by treatment with additional H2O. The crude product (cy-
clometalated chloride-bridged IrIII dimer, [Ir(C^N)2(m-Cl)2]) was
washed with hexanes and cold diethyl ether several times, dried,
and used without further purification.[24]
A mixture of the cyclometalated chloride-bridged IrIII dimer
(353 mg, 0.28 mmol), 1 (150 mg, 0.83 mmol), and Na2CO3 (294 mg,
2.8 mmol) was dissolved in 2-ethoxyethanol. The mixture was
heated at reflux under N2 (g) for 12 h. After cooling to room tem-
perature, the solution was concentrated, followed by the addition
of H2O. The organic phase was extracted with CH2Cl2 three times.
The collected organic solution was dried with Na2SO4 and the sol-
vent was removed under reduced pressure. The crude materials
were purified by column chromatography (SiO2, 50:1 CH2Cl2/
CH3OH, Rf = 0.6) to give the product as a red powder (340 mg,
80 %). FTIR (neat): ñ= 3057, 2021, 1608, 1516, 1437, 1381, 1338,
1163, 1028, 762 cm@1; UV/Vis (H2O): lmax (e) = 463 nm (5.78 (:
0.12) V 103 m@1 cm@1). 1H NMR (400 MHz, CDCl3): d = 8.79 (d, J =
8.0 Hz, 1 H), 8.13 (t, J = 8.0 Hz, 1 H), 8.07 (m, 3 H), 7.92 (dd, J =
8.0 Hz, 1 H), 7.80 (dd, J = 8.0 Hz, 1 H), 7.70 (dd, J = 8.0 Hz, 1 H), 7.67
(dd, J = 8.0 Hz, 1 H), 7.51 (m, 2 H), 7.42 (d, J = 8.0 Hz, 1 H), 7.39 (ddd,
1 H) 7.26 (ddd, 1 H), 7.03 (m, 2 H), 6.95 (m, 2 H), 6.89 (dd, J = 8.0 Hz,
1 H), 6.72 (m, 1 H), 6.60 (dt, J = 6.8 Hz, 1 H), 6.30 (m, 2 H), 2.87 ppm
(s, 6 H); 13C NMR (100 MHz, CDCl3): d = 173.0, 171.1, 169.2, 154.4,
151.8, 151.4, 148.7, 147.8, 147.0, 145.9, 145.1, 138.1, 136.3, 134.8,
129.4, 128.5, 126.0, 125.2, 121.5, 120.5, 116.1, 109.7, 108.8,
39.1 ppm; HRMS: m/z calcd for C38H29IrN4NaO2 [M + Na]
+ :
789.1812; found: 789.1814; elemental analysis calcd (%) for
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C38H29IrN4O2·0.5 CH3OH: C 59.14, H 4.00, N 7.17; found: C 59.00, H
4.01, N 7.19.
Electrospray ionization ion mobility mass spectrometry (ESI-
IM-MS)
Ab40, a-Syn, hIAPP, and ubiquitin (100 mm) were incubated with Ir-
1 or 1 (500 mm) in 100 mm ammonium acetate (pH 7.5) at 37 8C
without any agitation. Incubated peptides were diluted 10-fold
and then injected into a mass spectrometer. The capillary voltage,
sampling cone voltage, and source temperature were set to 2.8 kV,
70 V, and 40 8C, respectively. The backing pressure was adjusted to
3.2 mbar. Ion mobility wave height and velocity were adjusted to
10 V and 450 m s@1, respectively, and gas flow for the helium cell
and ion mobility cell was set to 120 and 30 mL min@1, respectively.
Tandem MS (MS2) analyses were additionally performed on the
nonoxidized (Figure S8 in the Supporting Information) and singly/
doubly oxidized peptides. The ESI parameters and experimental
conditions were same as those reported above. Collision-induced
dissociation was conducted by applying the collision energy in the
trap and adjusting LM resolution to 15. More than 200 spectra
were obtained for each sample and averaged for analyses. To esti-
mate collision cross-section values for obtained IM-MS data, cali-
bration was also performed by following previously reported pro-
cedures (Figure S9 in the Supporting Information).[25]
Mass spectrometric analyses
Oxidized Ab40, a-Syn, hIAPP, and ubiquitin were observed upon in-
cubation with Ir-1 under aerobic conditions in the presence of
light by using a Waters Synapt G2-Si Q-ToF mass spectrometer
equipped with an ESI source. Only major charge states of all pep-
tides (+ 3 for Ab40 and hIAPP, + 9 for a-Syn, and + 5 for ubiquitin)
were selected and shown in all mass spectra. Generally, exact mass
should be calculated based on monoisotopic mass; however, in
the present study, the oxidized peaks were assigned based on m/z
values of the most abundant peaks because monoisotopic mass
values of a-Syn could not be well resolved without a high-resolu-
tion mass spectrometer. For example, + 3-charged Ab40 was most
dominantly found in ESI-MS (Figure 2 a). Upon treatment of Ir-
1 and light, the singly oxidized Ab40 ions were abundantly ob-
served at 1449.6 m/z, corresponding to a 16 Da increase in mass
from the nonoxidized Ab40 peak at 1444.2 m/z (Figure 2 a, bottom;
blue). In the case of + 9-charged a-Syn at 1607.8 m/z, the singly
oxidized peak was not well defined due to overlap with sodiated
ions at 1610.2 m/z. With the treatment of Ir-1 and light, doubly
oxidized a-Syn was found at 1611.3 m/z, which indicated an ap-
proximate 32 Da increase in mass (Figure 2 b, bottom; blue). The
+ 3-charged hIAPP presented an oxidized peak at 1306.9 m/z, indi-
cating a 14 Da difference in mass from nonoxidized ions with
1302.2 m/z upon treatment with Ir-1 and light (Figure 2 c, bottom;
blue). Different from Ab40 and a-Syn, singly oxidized hIAPP indicat-
ed a 14 Da increase in mass. In the ESI-MS spectra of ubiquitin, the
+ 5 charge state was most abundantly detected (Figure S4 in the
Supporting Information). Singly and doubly oxidized ubiquitin
were found at 1717.2 and 1720.3 m/z, respectively, which were ap-
proximately 16 and 32 Da increases in mass from nonoxidized
ubiquitin centered at 1713.9 m/z (Figure S4 in the Supporting In-
formation, bottom; blue).
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